Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.10.2021Zentiva k.s. (ZNT-3)4696DXanirva 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva k.s. (ZNT-3)4699DXanirva 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/Al))19.10.2021O
 18.10.2021Zentiva, k.s. (ZNT-1)5802BMixor 80 mg/5 mg (tbl 28x80 mg/5 mg (blis.OPA/Al/PVC/Al))19.10.2021O
 18.10.2021Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)42283Eligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))18.10.2021R
 15.10.2021LEO Pharma A/S (LEO-2)0701BDaivobet gél (gel der 1x60 g (fľ.HDPE+aplikátor PP))1.11.2021Z
 15.10.2021LEO Pharma A/S (LEO-2)30770Daivobet gél (gel der 1x60 g (fľ.HDPE))1.11.2021Z
 15.10.2021GlaxoSmithKline (Ireland) Limited (GAG-IE-2)46800INTEGRILIN 2 mg/ml injekčný roztok (sol inj 1x10 ml/20 mg (liek.inj.skl.))15.10.2021R
 14.10.2021Takeda Manufacturing Austria AG (TKM-5)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))14.10.2021O
 14.10.2021Takeda Manufacturing Austria AG (TKM-5)97247KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x50 ml/5 g (liek.inj.skl.))13.10.2021R
 14.10.2021Teva B.V. (TEV-NL-4)1220BSastravi 150 mg/37,5 mg/200 mg (tbl flm 100x150 mg/37,5 mg/200 mg (obal HDPE))27.11.2021R
 14.10.2021Teva B.V. (TEV-NL-4)83405Irbesartan Teva 300 mg filmom obalené tablety (tbl flm 28x300 mg (blis.PVC/PVDC/Al))15.10.2021O
 14.10.2021Teva B.V. (TEV-NL-4)84800Irbesartan/Hydrochlorothiazid Teva 300 mg/12,5 mg filmom obalené tablety (tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDC/Al))15.10.2021O
 13.10.2021sanofi-aventis groupe (SOI-1)58809CLEXANE FORTE 12000 IU (120 mg)/0,8 ml (sol inj 10x0,8 ml/120 mg (striek.inj.napl.skl.) s bezp.systémom (E))15.12.2021R
 13.10.2021BB Pharma a.s. (BBP-CZ-1)2194BPENDEPON COMPOSITUM (plv inu 1x1,5 MU (liek.inj.))7.7.2021O
 12.10.2021Accord Healthcare S.L.U (ACC-ES)12386Levetiracetam Accord 1000 mg filmom obalené tablety (tbl flm 100x1000 mg (blis.PVC/Al))14.10.2021R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)